From the Department of Nuclear Medicine, The Affiliated Hospital of Southwest Medical University; Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province; Academician (Expert) Workstation of Sichuan Province, Luzhou, Sichuan; Department of Nuclear Medicine, Zhongshan Hospital, Fudan University; Nuclear Medicine Institute of Fudan University; and Shanghai Institute of Medical Imaging, Shanghai, China.
Clin Nucl Med. 2022 May 1;47(5):449-450. doi: 10.1097/RLU.0000000000003996.
A 73-year-old man with newly diagnosed nasopharyngeal carcinoma included in a clinical trial of 68Ga-FAPI PET/CT study in tumors (ChiCTR2100044131). Increased tracer uptake was noted in nasopharyngeal carcinoma and cervical lymph nodes metastases. In addition, avascular necrosis of right femoral head also revealed increased FAPI activity.
一位 73 岁男性,新诊断为鼻咽癌,参与了一项肿瘤 68Ga-FAPI PET/CT 研究的临床试验(ChiCTR2100044131)。在鼻咽癌和颈部淋巴结转移灶中观察到示踪剂摄取增加。此外,右侧股骨头无菌性坏死也显示出 FAPI 活性增加。